TrialInternational journal of molecular sciences2025

Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial.

Rosaura Casas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.